3Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus[J]. N Engl J Med, 1995, 333: 550-554.
4Jackson RA, Hawa MI, Jaspan JB, et al. Mechanism of metformin action in non-insulin-dependent diabetes[J]. Diabetes, 1987, 36: 632- 640.
5Cusi K, Defronzo RA. Metformin: a review of its metabolic effects[J]. Diabetes Reviews, 1998, 6: 89.
7Rodriguez-Moctezuma JR, Robles-Lopez G, Lopez-Carmona JM, et al. Effects of metformin on the body composition in subjects with risk factors for type 2 diabetes[J]. Diabetes Obes Metab, 2005, 7: 189-192.
8Tankova T. Current indications for metformin therapy[J]. Rom J Intern Med, 2003, 41 (3): 215-225.
9United Kingdom Prespective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complication in overweight patients with type 2 diebetes (UKPDS 34)[J]. Lancet, 1998, 352: 854-865.
10Donnelly LA, Doney AS, Hattersley AT, et al. The effect of obesity on glycaemic response to metformin or sulphonglureas in type 2 diabetes[J]. Diebetes Med, 2006, 23: 128-133.
4[1]Bonow RO,Gheorghiade M.The diabetes epidemic:a national and global crisis[J].Am J Med,2004,116(S):5A-2S
5[2]U.K.Prospective Diabetes Study Group.UKPDS 28:a randomized trial of efficacy of early addition of metformin in sulfonylures-treated type 2 diabetes[J].Diabe Care,1998,21 (1):87-92
6[3]Blonde L,Wogen J,Kreilick C,et al.Greater reductions in A1C intype 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin[J].Diabe Obes Metab,2003,5 (6):424-431
7[4]Melikian C,White TJ,Vanderplas A,et al.Adherence to oral antidiabetic therapy in a managed care organization:a comparison of monotherapy,combination therapy,and fixed-dose combination therapy[J].Clin Ther,2002,24 (3):460-467
8[5]Guillausseau PJ.Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes.A survey in general practice[J].Dia be Metab,2003,29(1):79-81
9Johansen K.Efficacy of meffonnin in the treatment of NIDDM. Diabetes Car,1999,22:33-37.
10Lenhard JM,Kliewer SA,Paulik MA,et al. Effects of trrroglitazone and metformin on glucose and lipid metabolism: alteration of two distinct molecular partway. Diabetes, 1999,48 : 1251-1257.
8Danaei G, Finucane MM, Yu L, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies With 370 country-years and 2.7 million participants [ J ]. The Lancet,2011,378 (9785) :31 - 40.
9Tahrani AA, Bailey C J, Del-Prato S, et al. Management of type 2 diabe- tes : new and future development in treatment[J].The Lancet,2011,378 (9786) :182 - 197.
10Deusenberry CM, Coley KC, Korytkowski MT, et al. Hypoglycemia in hospitalized patients treated with sulfonylureas [ J ]. Pharmacotherapy, 2012,32(7) :613 -617.
